Publication | Open Access
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse
28
Citations
32
References
2023
Year
In the setting of novel therapy, 1q gain/amp still acts as an independent adverse prognostic factor. Patients with 1q gain/amp achieved VGPR rapidly but had inferior survival.
| Year | Citations | |
|---|---|---|
Page 1
Page 1